DEA Announcement Regarding Registration Renewals
DEA has announced that starting January 1, 2017, only one renewal notification will be sent to the registrant. Additionally, renewal applications must be received no later than the current license expiration date. If you allow your license to expire, a new application must be submitted. Late renewal applications will not be accepted by the DEA.
This notice affects both Researchers (renewal form 225a) and Practitioners (renewal form 224a). The notice, “Change in DEA Registration Application Renewal Notification Reminder”, can be viewed at: https://www.deadiversion.usdoj.gov/drugreg/index.html
This publication provides faculty and staff members with information about some of the major policies and regulatory requirements that govern employee activities and introduces employees to the strong ethical principles that form the basis for Emory’s mission and work. We hope this publication will serve both as a useful overview for new employees, and a handy reference guide for current faculty and staff.
The manual is available here
Follow us on Twitter:Follow @EmoryCompliance
Contact us at email@example.com or 404-727-2398.
Emory policies on Research Misconduct, and the Guidelines for Responsible Conduct of Scholarship and Research have been updated and there is a new policy on Authorship Guidelines and Dispute Resolution. For more information click here.
Global Services and the Office of Compliance worked together to create an assessment tool to assist the Office of Compliance in identifying activities that require additional assessment under export control and related regulations, and to enable Global Services to provide assistance with the various administrative and business considerations (e.g., HR, travel) that international projects can involve. More information available here.
A tutorial on the use of "Dangerous Drugs" in research is available.
The Office of Compliance assists investigators, coordinators and the Emory research community by providing education and consultation regarding regulatory requirements, compliance obligations and best practices. Specific information, forms and templates are available for Sponsor Investigators conducting Device Studies and Drug Studies.